Sir -We read with interest the paper by Galante et al. (1986) , reporting that mass tumour doubling time can be calculated from double mammographic examination with an interval of greater than 20 days. We have carried out double mammographic examinations on 10 patients and examined intra-and inter-personal variation in this method of measuring breast carcinomas.
Two radiographers took all the X-rays. Both were experienced in mammographic interpretation and they were asked to assess the size of the mammographic lesions. One radiographer assessed the mammograms on two separate occasions to enable intra-personal variation to be assessed. The other radiographer assessed the mammograms once to enable inter-personal variation to be assessed. All mammograms were presented to the radiographers in a random manner with the patients name and the date of examination obscured from view. The volume of the tumours was calculated as suggested by Galante et al. The results are shown in Table I .
We have not found double mammographic examination an accurate reproducible method for estimating the volume of breast tumours and thereby calculating growth rate. Table  I shows a degree of intra-personal consistency in the measurement of V0 and V1 suggesting there is an inherent inaccuracy in the double mammographic technique as a method of calculating growth rate. The wide inter-personal variation suggests that results are also observer-dependent.
We find it difficult to believe that growth rates calculated in this manner can give reliable prognostic information. The alternative conclusion from our results is that 0.1 rad is Dr Galante replies Sir -The objections made by the colleagues of the Helen Garrod Breast Screening Unit are relevant, but the conclusions are not. All research on biological processes is subject to two variable factors: the process itself, which is rarely consistently repeatable, and human error. For this reason, it is known that histological samples examined by different pathologists can frequently be interpreted in different ways; blood tests carried out at different laboratories may give different numerical results; and in the specific field of neoplastic growth, studies on cellular kinetics, which can be considered the best for measuring this phenomenon, still, for the same reason, attract wide criticism.
During the course of our research, we also questioned the degree of reliability of this method, and therefore had 5 different radiologists read 12 mammograms, one of whom had already previously read the mammograms. With the exception of one radiologist, the numerical results of the other 4 differed by 1-2 mm, which means 0.5-1 mm marginal difference. But what stimulated us to continue the work was the observation that, apart from some numerical variations, the reported reading of the radiologists all confirmed one characteristic: if the tumor grew, it grew for all four of them; if it did not grow, it did not grow for any of them.
The remaining goal was therefore to reduce the human error. For this reason, as reported in a previous publication (Galante et al., Tumori, 67, 333, 1981) , we used (a) the same radiographic equipment for the first and second examinations; (b) the same person to carry out the mammograms; and (c) the same radiologist, to read both mammograms (the first and the second), thus assuming that human error in the readings, if repeated, would be cancelled out, and moreover, the not so clearly identifiable neoplasm excluded.
Proposal of the method as 100% error-free was not the point of our study, the main aim being rather to study the relationship between certain growth characteristics of the primary tumour and the course of disease. Although the method has certain limitations, the follow-up study still seems to produce some valid conclusions. For us this is a successful result.
At present we are continuing our studies and hopefully plan to publish, within the following year, a paper concerning a semi-automatic system (computer+radiologist), which could further reduce the human error.
Yours etc.
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